S J Imm

No ORCID on file · 5 papers in corpus · active 2021-2023

Study types

  • article 5

Condition tags

  • endometriosis 5
  • dysmenorrhea 2
article 2023
Impact of Time Since Surgical Diagnosis of Endometriosis on Outcomes with Relugolix Combination Therapy: Spirit Long-Term Extension (LTE)
·doi:10.1016/j.jmig.2023.08.031
article 2023
O-032 Effect of relugolix combination therapy in women with endometriosis-associated pain who received prior first-line hormonal treatment: SPIRIT 1 and 2
·doi:10.1093/humrep/dead093.032

Abstract Study question To assess the effect of oral relugolix combination therapy (Relugolix-CT) in the subgroup of women with endometriosis-associated pain who received prior first-line hormonal treatment. Summary answer Relugolix-CT sign…

article 2022
70 Effects of relugolix combination therapy on endometriosis-associated pain and analgesic use in spirit studies: overall study and european populations
·doi:10.1016/j.ejogrb.2021.11.131
article 2021
O-131 The effect of time since surgical diagnosis of endometriosis on treatment outcomes with relugolix combination therapy in women with endometriosis-associated pain: SPIRIT program
·doi:10.1093/humrep/deab126.056

Abstract Study question To assess the efficacy of Relugolix-CT vs placebo in women who were surgically diagnosed with endometriosis <5 and > = 5 years ago. Summary answer Treatment outcomes did not differ for dysmenorrhea and daily fu…

article 2021
The Effect of Time Since Surgical Diagnosis of Endometriosis on Treatment Outcomes with Relugolix Combination Therapy: Spirit Program
·doi:10.1016/j.jmig.2021.09.032